Get the Stockscreener App
9.61
1.03%
-0.10
After Hours:
9.80
0.19
+1.98%
Embecta Corp stock is traded at $9.61, with a volume of 824.72K.
It is down -1.03% in the last 24 hours and down -15.33% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$9.71
Open:
$9.72
24h Volume:
824.72K
Relative Volume:
1.07
Market Cap:
$569.10M
Revenue:
$1.10B
Net Income/Loss:
$83.60M
P/E Ratio:
6.7203
EPS:
1.43
Net Cash Flow:
$132.30M
1W Performance:
-6.88%
1M Performance:
-15.33%
6M Performance:
-33.68%
1Y Performance:
-23.73%
1-Day Range:
$9.61
$9.84
1-Week Range:
$9.59
$10.62
52-Week Range:
$9.20
$15.55
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
9.61 | 575.02M | 1.10B | 83.60M | 132.30M | 1.43 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
William Blair Investment Management LLC Sells 312,857 Shares of Embecta Corp. $EMBC - MarketBeat
Precision Trading with Embecta Corp. (EMBC) Risk Zones - Stock Traders Daily
InvestingPro’s Fair Value spotted Embecta overvaluation before 47% drop By Investing.com - Investing.com South Africa
EMBCEmbecta Corp Latest Stock News & Market Updates - Stock Titan
Embecta Corp. (EMBC) Stock Analysis: Attractive Dividend Yield and Significant Upside Potential Beckon Investors - DirectorsTalk Interviews
EMBC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Drivers: Why is Embecta Corp stock going upWeekly Volume Report & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Embecta Corp. (EMBC) Stock Analysis: A 58.28% Potential Upside In Medical Device Innovation - DirectorsTalk Interviews
Public Sector Pension Investment Board Increases Stock Position in Embecta Corp. $EMBC - MarketBeat
Technical Reactions to EMBC Trends in Macro Strategies - Stock Traders Daily
Does Embecta Corp. have high return on assets2025 Volatility Report & Safe Swing Trade Setup Alerts - mfd.ru
Embecta shareholders back board, pay, and equity plan - The Globe and Mail
Will Embecta Corp. stock gain from lower inflationPortfolio Performance Report & High Conviction Buy Zone Alerts - mfd.ru
Why analysts remain bullish on Embecta Corp. stockPortfolio Return Summary & Reliable Price Breakout Signals - mfd.ru
Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively - simplywall.st
Why Embecta's (NASDAQ:EMBC) Earnings Are Better Than They Seem - 富途牛牛
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance
Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business
Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative
embecta names new Chairman of the Board and Lead Independent Director - The Manila Times
What’s the RSI of Embecta Corp. stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15 - Yahoo Finance
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN
Can Embecta Corp. stock surprise with earnings upside2025 Stock Rankings & Low Risk High Reward Trade Ideas - mfd.ru
Embecta Announces Board Changes, Effective February 11, 2026 - marketscreener.com
Embecta (NASDAQ:EMBC) Trading Down 5%Should You Sell? - MarketBeat
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Embecta Corp. Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next - 富途牛牛
Trading the Move, Not the Narrative: (EMBC) Edition - Stock Traders Daily
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15 - simplywall.st
Embecta Earnings Call: U.S. Headwinds, Global Offsets - The Globe and Mail
Embecta (NASDAQ:EMBC) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
3 Healthcare Stocks Paying the Highest Dividends of 2026 - The Motley Fool
Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target - TipRanks
BTIG Research Reiterates "Buy" Rating for Embecta (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Reiterates Buy Rating on Embecta (EMBC) with Stable Price T - GuruFocus
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline By Investing.com - Investing.com South Africa
Embecta (EMBC) Margin Rebound And 4.4x P E Challenge Cautious Narratives - simplywall.st
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline - Investing.com Nigeria
Embecta Corp. (NASDAQ:EMBC) to Issue $0.15 Quarterly Dividend - MarketBeat
Embecta Q1 Earnings Call Highlights - MarketBeat
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges By GuruFocus - Investing.com Canada
Embecta reports Q1 adjusted EPS 71c, consensus 67c - TipRanks
Embecta (NASDAQ:EMBC) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Embecta Q1 2026 Earnings Call Transcript - MarketBeat
Embecta Corp. SEC 10-Q Report - TradingView
Revenue Check: What is the PEG ratio of Embecta CorpQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Embecta (NASDAQ:EMBC) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Embecta stock ticks up on Street-beating Q1 - Drug Delivery Business
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):